Related Guides
Deeper context, comparisons, and practical research paths.
Herb Profile
Ocotea Odorifera
Ocotea Odorifera carries a Grade C rating — limited evidence.
Last reviewed: •4 sources citedReport a correctionProfile-wide ·C Limited
Use extra caution — Safrole related safety concerns; avoid concentrated internal use and pregnancy. Details
- Evidence
- Limited Evidence
- Typical onset
- Varies by prep
- Safety rating
- High caution
- Best for
- Anti Inflammatory, Inflammatory signaling
- Avoid / review if
- Young Children Due To The Same Safrole Carcinogenicity And Hepatotoxicity Caution
At a glance
From this profile's structured data- Evidence
- Grade C
- Safety
- Safrole-related safety concerns; avoid concentrated internal use and pregnancy.
- Profile context
- anti-inflammatory
Next stepsWhere to go next — guides & comparisons
Continue reading
- If you want to browse more herbs → All herbs
Safety
Safety & Cautions
Safrole related safety concerns; avoid concentrated internal use and pregnancy.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- Young Children Due To The Same Safrole Carcinogenicity And Hepatotoxicity Caution
Safety classifications
- Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.
Full safety note
- Safrole related safety concerns; avoid concentrated internal use and pregnancy.
Safety labels
- Pregnancy/Breastfeeding Caution
Evidence
Evidence Summary
Evidence lens
Read as directional context, not settled clinical proof.
LimitedLimited Evidence
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Safrole related safety concerns; avoid concentrated internal use and pregnancy.
This profile cites 4 human studies.
Study design details
Evidence Grade
Grade C: Limited Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Narrative review
- Risk of Bias
- High
- Consistency
- Not assessed
Strongest recorded design is a narrative review, drawn from 1 recorded study, none of which measured an outcome in people.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (5)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
Filter by study class
Showing 5 of 5 studies.
What the evidence actually shows
This table contains 5 structured sources, including 0 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Achimón F et al. · Plants (Basel) · 2022 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
de Alcântara BGV et al. · J Ethnopharmacol · 2021 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Gontijo DC et al. · Food Chem · 2017 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Comprehensive toxicity study of safrole using a medium-term animal model with gpt delta rats Jin M et al. · Toxicology · 2011 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | A 2025 propagation study treats Ocotea odorifera as a threatened Atlantic Forest tree. This is not efficacy evidence, but it is important sourcing/conservation context for a commercial botanical profile. | PubMed → |
Dosing & Timing
- No standardized dose
- Preparation specific; use standardized product label for Aromatic herb/spice forms and essential oils differ greatly and require source backed dosage review before therapeutic claims.
How Ocotea Odorifera works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Ocotea Odorifera Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
- Inflammatory Signaling Modulation
Active Compounds
Key constituents studied in Ocotea Odorifera, with full pharmacology and safety profiles.
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Guides that use Ocotea Odorifera
Condition guides
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Ocotea Odorifera research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.